GDNF induces a dystonia-like state in neonatal rats and stimulates dopamine and serotonin synthesis

Neuron

Volumn 16, Issue 3, 1996, Pages 665-673

  Beck, Klaus D ^a,c   Irwin, Ian ^b   Valverde, Janet ^a   Brennan, Thomas J ^a   Langston, J William ^b   Hefti, Franz ^a  

^a GENENTECH INC   (United States)

^b PARKINSON S INSTITUTE   (United States)

^c PFIZER INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOBUTYRIC ACID; DOPAMINE; NEURITE PROMOTING FACTOR; NEUROTROPHIC FACTOR; SEROTONIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BEHAVIOR; CONTROLLED STUDY; DOPAMINE METABOLISM; DYSTONIA; IMMUNOREGULATION; INTRACEREBROVENTRICULAR DRUG ADMINISTRATION; MESENCEPHALON; NERVE SPROUTING; NEUROTRANSMITTER RELEASE; NONHUMAN; PRIORITY JOURNAL; RAT; SEROTONIN RELEASE; SUBSTANTIA NIGRA;

EID: 0029878449     PISSN: 08966273     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0896-6273(00)80085-9     Document Type: Article

References (53)

1. Adams, R.D., and Victor, M. (1993). Principles of Neurology, Fifth Edition (New York: McGraw-Hill).
2. Arbogast, L.A., and Voogt, J.L. (1991). Ontogeny of tyrosine hydroxylase mRNA signal levels in central dopaminergic neurons: development of a gender difference in the arcuate nuclei. Dev. Brain Res. 63, 151-161.
3. Azmitia, E., and Segal, M. (1978). An autoradiographic analysis of the differential ascending projections of the dorsal and median raphe nuclei in the rat. J. Comp. Neurol. 79, 641-659.
4. Beck, K.D. (1994). Functions of brain-derived neurotrophic factor, des(1-3)insulin-like growth factor-I and basic fibroblast growth factor in the development and maintenance of dopaminergic neurons. Prog. Neurobiol. 44, 497-516.
5. Beck, K.D., Valverde, J., Alexi, T., Poulsen, K., Moffat, B., Vandlen, R.A., Rosenthal, A., and Hefti, F. (1995). Mesencephalic dopaminergic neurons protected by GDNF from axotomy-induced degeneration in the adult brain. Nature 373, 339-341.
6. Beninger, R.J. (1983). The role of dopamine in locomotor activity and learning. Brain Res. Rev. 6, 173-196.
7. Benloucif, S., and Galloway, M.P. (1991). Facilitation of dopamine release in vivo by serotonin agonists: studies with microdialysis. Eur. J. Pharmacol. 200, 1-8.
8. Bergman, J., Madras, B.K., Johnson, S.E., and Spealman, R.O. (1989). Effects of cocaine and related drugs in nonhuman primates. III. Self-administration by squirrel monkeys. J. Pharmacol. Exp. Ther. 251, 150-155.
9. Broaddus, W.C., and Bennett, J.P., Jr. (1990). Postnatal development of striatal dopamine function. I. An examination of D1 and D2 receptors, adenylate cyclase regulation and presynaptic dopamine markers. Dev. Brain Res. 52, 265-271.
10. Buj-Bello, A., Buchman, V.L., Horton, A., Rosenthal, A., and Davies, A.M. (1995). GDNF is an age-specific survival factor for sensory and autonomic neurons. Neuron 15, 821-828.
11. Casper, D., Mytilineou, M., and Blum, J. (1991). EGF enhances the survival of dopaminergic neurons in rat embryonic mesencephalic primary cell culture. J. Neurosci. Res. 30, 372-381.
12. Choi-Lundberg, D.L., and Bohn, M.C. (1995). Ontogeny and distribution of glial cell line-derived neurotrophic factor (GDNF) mRNA in rat. Dev. Brain Res. 85, 80-88.
13. Dewey, S.L., Smith, G.S., Logan, J., Alexoff, D., Ding, Y.-S., King, P., Pappas, N., Brodie, J.D., and Ashby, C.R., Jr. (1995). Serotonergic modulation of striatal dopamine measured with positron emission tomography (PET) and in vivo microdialysis. J. Neurosci. 15, 821-829.
14. Dray, A., Davies, J., Oakley, N., and Tanner, T. (1976). Evidence for the existence of a raphe projection to the substantia nigra in the rat. Brain Res. 113, 45-57.
15. Dray, A., Davies, J., Oakley, N., Tongroach, P., and Velluci, S. (1978). The dorsal and medial raphe projections to the substantia nigra in the rat: electrophysiological, biochemical and behavioral observations. Brain Res. 151, 431-442.
16. Ebendal, T., Tomac, A., Hoffer, B.J., and Olson, L. (1995). Glial cell line-derived neurotrophic factor stimulates fiber formation and survival in cultured neurons from peripheral autonomic ganglia J. Neurosci. Res. 40, 276-284.
17. Ferre, S., Cortes, R., and Artigas, F. (1994). Dopaminergic regulation of the serotonergic raphe-striatal pathway: microdialysis studies in freely moving rats. J. Neurosci. 14, 4839-4846.
18. Greenberg, D., Banerjee, S.P., Yamamura, H.I., and Snyder, S.H. (1974). Drugs, neuro-transmitters, and schizophrenia. Science 184, 1243-1253.
19. Henderson, C.E., Phillips, H.S., Pollock, R.A., Davies, A.M., Lemeulle, C., Armanini, M., Simmons, L., Moffet, B., Vandlen, R.A., Koliatsos, V.E., and Rosenthal, A. (1994). GDNF: a potent survival factor for motoneurons present in peripheral nerve and muscle. Science 266, 1062-1064.
20. Herve, D.H., Pickel, V.M., Joh, T.H., and Beaudet, A. (1987). Serotonin axon terminals in the ventral tegmental area of the rat: fine structure and synaptic input to dopaminergic neurons. Brain Res. 435, 71-83.
21. Ho, A., Gore, A.C., Weickert, C.S., and Blum, M. (1995). Glutamate regulation of GDNF gene expression in the striatum and primary striatal astrocytes. Neuroreport 6, 1326-1330.
22. Hoffer, B.J., Hoffman, A., Bowenkamp, K., Huetti, P., Hudson, J., Martin, D., Lin, L.-F.H., and Gerhardt, G.A. (1994). Glial cell line-derived neurotrophic factor reverses toxin-induced injury to midbrain dopaminergic neurons in vivo. Neurosci. Lett. 182, 107-111.
23. Huang, X., and Nichols, D.E. (1993). 5-HT2 receptor-mediated potentiation of dopamine synthesis and central serotonergic deficits. Eur. J. Pharmacol. 238, 291-296.
24. Hudson, J., Granholm, A.C., Gerhardt, G.A., Henry, M.A., Hoffman, A., Biddle, P., Leela, N.S., Mackerlova, L., Lile, J.D., and Collins, F. (1995). Glial cell line-derived neurotrophic factor augments midbrain dopaminergic circuits in vivo. Brain Res. Bull. 36, 425-432.
25. Irwin, I., DeLanney, L.E., Forno, L.S., Finnegan, K.T., DiMonte, D.A., and Langston, J.W. (1990). The evolution of nigrostriatal neurochemical changes in the MPTP-treated squirrel monkey. Brain Res. 531, 242-252.
26. 3H]Mazindol binding associated with neuronal dopamine and norepinephrine uptake sites. Mol. Pharmacol. 26, 35-44.
27. Kalen, P., Skagerberg, G., and Lindvall, O. (1988). Projections from the ventral tegmental area and mesencephalic raphe to the dorsal raphe nucleus in the rat. Exp. Brain Res. 73, 69-77.
28. Kearns, C.M., and Gash, D.M. (1995). GDNF protects nigral dopamine neurons against 6-hydroxydopamine in vivo. Brain Res. 672, 104-111.
29. Kilpatrick, L., Jones, M., and Phillipson, O. (1986). A semiautomated analysis method for catecholamines, indoleamines, and some prominent metabolites in microdissected regions of the nervous system: an isocratic HPLC technique employing coulometric detection and minimal sample preparation. J. Neurochem. 46, 1865-1876.
30. Krieglstein, K., and Unsicker, K. (1994). Transforming growth factor β promotes survival of midbrain dopaminergic neurons and protects them against N-methyl-4-phenylpyridinium ion toxicity. Neuroscience 63, 1189-1196.
31. Lapchak, P.A., Beck, K.D., Araujo, D.M., Irwin, I., Langston, J.W., and Hefti, F. (1993). Chronic intranigral administration of BDNF produces striatal dopaminergic hypofunction in unlesioned adult rats and fails to attenuate the decline of striatal dopaminergic function following medial forebrain bundle transection. Neuroscience 53, 639-650.
32. Lin, L.-F.H., Doherty, D.H., Lile, J.D., Bektesh, S., and Collins, F. (1993). GDNF: a glial cell line-derived neurotrophic factor for midbrain dopaminergic neurons. Science 260, 1130-1132.
33. Nedergaard, S., Bolam, J.P., and Greenfield, S.A. (1988). Facilitation of a dendritic calcium conductance by 5-HT in the substantia nigra. Nature 333, 174-177.
34. Oppenheim, R.W., Houenou, L.J., Johnson, J.E., Lin, L.-F.H., Li, L., Lo, A.C., Newsome, A.L., Prevette, D.M., and Wang, S. (1995). Developing motor neurons rescued from programmed and axotomy-induced cell death by GDNF. Nature 373, 344-346.
35. Pasquier, D.A., Kemper, T.L., Forbes, W.B., and Morgane, P.J. (1977). Dorsal raphe, substantia nigra and locus coeruleus: interconnections with each other and the neostriatum. Brain Res. Bull. 2, 323-339.
36. Poulsen, K.T., Armanini, M.P., Klein, R.D., Hynes, M.A., Phillips, H.S., and Rosenthal, A. (1994). TGFβ2 and TGFβ3 are potent survival factors for midbrain dopaminergic neurons. Neuron 13, 1245-1252.
37. Sauer, H., Rosenblad, C., and Bjorklund, A. (1995). GDNF but not TGF-β3 prevents delayed degeneration of nigral dopaminergic neurons following striatal neurotoxic lesions. Proc. Natl. Acad. Sci. USA, in press.
38. Schaar, D.G., Sieber, B.-A., Dreyfuss, C.F., and Black, I.B. (1993). Regional and cell-specific expression of GDNF in rat brain. Exp. Neurol. 124, 368-371.
39. Schmidt-Kastner, R., Tomac, A., Hoffer, B., Bektesh, S., Rosenzweig, B., and Olson, L. (1994). Glial cell line-derived neurotrophic factor (GDNF) mRNA upregulation in striatum and cortical areas after pilocarpine-induced status epilepticus in rats. Mol. Brain Res. 26, 325-330.
40. Specht, L.A., Pickel, V.M., Joh, T.H., and Reis, D.J. (1981a). Fine structure of the nigrostriatal anlage in fetal rat brain by immunocytochemical localization of tyrosine hydroxylase. Brain Res. 218, 49-65.
41. Specht, L.A., Pickel, V.M., Joh, T.H., and Reis, D.J. (1981b). Light-microscopic immunocyto-chemical localization of tyrosine hydroxylase in prenatal rat brain. II. Late ontogeny. J. Comp. Neurol. 199, 255-276.
42. Springer, J.E., Mu, X., Bergmann, L.W., and Trojanowski, J.Q. (1994). Expression of GDNF mRNA in rat and human nervous tissue. Exp. Neurol. 127, 167-170.
43. Stroemberg, I., Bjorklund, L., Johannsson, M., Tomac, A., Collins, F., Olson, L., Hoffer, B., and Humpel, C. (1993). Glial cell line-derived neurotrophic factor is expressed in the developing but not adult striatum and stimulates developing dopamine neurons in vivo. Exp. Neurol. 124, 401-412.
44. Suter-Crazzolara, C., and Unsicker, K. (1995). GDNF is expressed in two forms in many tissues outside the CNS. Neuroreport 5, 2486-2488.
45. Tomac, A., Lindqvist, E., Lin, L.-F.H., Ogren, S., Young, D., Hoffer, B.J., and Olson, L. (1995a). Protection and repair of the nigrostriatal dopaminergic system by GDNF in vivo. Nature 373, 339-341.
46. Tomac, A., Widenfalk, J., Lin, L.-F.H., Kohno, T., Ebendal, T., Hoffer, B.J., and Olson, L. (1995b). Retrograde axonal transport of glial cell line-derived neurotrophic factor in the adult nigrostriatal system suggests a trophic role in the adult. Proc. Natl. Acad. Sci. USA 92, 8274-8278.
47. Trupp, M., Ryden, M., Jörnvall, H., Funakoshi, H., Timmusk, T., Arenas, E., and Ibáñez, C.F. (1995). Peripheral expression and biological activities of GDNF, a new neurotrophic factor for avian and mammalian peripheral neurons. J. Cell Biol. 130, 137-148.
48. Van Bockstaele, E., Biswas, A., and Pickel, V. (1993). Topography of serotonin neurons in the dorsal raphe nucleus that send axon collaterals to the rat prefrontal cortex and nucleus accumbens. Brain Res. 624, 188-198.
49. Venero, J.L., Beck, K.D., and Hefti, F. (1994). Introstriatal infusion of nerve growth factor after quinolinic acid prevents reduction of cellular expression of choline acetyltransferase mRNA and trkA mRNA, but not glutamate decarboxylase mRNA. Neurosci. 61, 257-268.
50. Voorn, P., Kalsbeek, A., Jorritsma-Byham, B., and Groenewegen, H.J. (1988). The pre- and postnatal development of the dopaminergic cell groups in the ventral mesencephalon and the dopaminergic innervation of the striatum of the rat. Neuroscience 25, 857-887.
51. Yadid, G., Pacak, K., Kopin, I.J., and Goldstein, D.S. (1994). Endogenous serotonin stimulates dopamine release in conscious rats. J. Pharmacol. Exp. Ther. 270, 1158-1165.
52. Yan, Q., Matheson, C., and Lopez, O.T. (1995). In vivo neurotrophic effects of GDNF on neonatal and adult facial motor neurons. Nature 373, 341-344.
53. Zurn, A.D., Baetge, E.E., Hammang, J.P., Tan, S.A., and Aebischer, A. (1995). GDNF, a new neurotrophic factor for motoneurones. Neuroreport 6, 113-118.